Search

everythinglearnresearchcommunity

for

Search:↓

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

IL-18 signaling helps mature Tregs move into the thymus.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

IL-18 signaling helps mature Tregs move into the thymus.

IL-17-producing γδ T cells help improve bone healing.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Blocking certain immune signals can reduce skin damage from radiation therapy.